Robust and generalizable artificial intelligence for multi-organ segmentation in ultra-low-dose total-body PET imaging: a multi-center and cross-tracer study.

PURPOSE

Positron Emission Tomography (PET) is a powerful molecular imaging tool that visualizes radiotracer distribution to reveal physiological processes. Recent advances in total-body PET have enabled low-dose, CT-free imaging; however, accurate organ segmentation using PET-only data remains challenging. This study develops and validates a deep learning model for multi-organ PET segmentation across varied imaging conditions and tracers, addressing critical needs for fully PET-based quantitative analysis.

MATERIALS AND METHODS

This retrospective study employed a 3D deep learning-based model for automated multi-organ segmentation on PET images acquired under diverse conditions, including low-dose and non-attenuation-corrected scans. Using a dataset of 798 patients from multiple centers with varied tracers, model robustness and generalizability were evaluated via multi-center and cross-tracer tests. Ground-truth labels for 23 organs were generated from CT images, and segmentation accuracy was assessed using the Dice similarity coefficient (DSC).

RESULTS

In the multi-center dataset from four different institutions, our model achieved average DSC values of 0.834, 0.825, 0.819, and 0.816 across varying dose reduction factors and correction conditions for FDG PET images. In the cross-tracer dataset, the model reached average DSC values of 0.737, 0.573, 0.830, 0.661, and 0.708 for DOTATATE, FAPI, FDG, Grazytracer, and PSMA, respectively.

CONCLUSION

The proposed model demonstrated effective, fully PET-based multi-organ segmentation across a range of imaging conditions, centers, and tracers, achieving high robustness and generalizability. These findings underscore the model's potential to enhance clinical diagnostic workflows by supporting ultra-low dose PET imaging.

CLINICAL TRIAL NUMBER

Not applicable. This is a retrospective study based on collected data, which has been approved by the Research Ethics Committee of Ruijin Hospital affiliated to Shanghai Jiao Tong University School of Medicine.